-
October 14, 2026
European enforcers have accepted commitments from Sanofi over concerns that it blocked competition from a rival flu vaccine for vulnerable patients by making disparaging statements to healthcare professionals in Germany and France.
-
October 13, 2026
Liquidia will pay out $380.7 million as part of a settlement agreement with United Therapeutics Corp. that resolves six lawsuits between the pharmaceutical companies, Liquidia announced Tuesday, saying patients will continue to have access to its Yutrepia lung disease treatment that was central to litigation.
-
October 13, 2026
Skadden Arps Slate Meagher & Flom LLP continues to grow its mass torts and products liability litigation offerings in its Chicago office with the addition of five veteran litigators from DLA Piper, the firm announced on Tuesday.
-
October 13, 2026
A Delaware federal judge found cracks in a biotechnology company's jurisdictional arguments in a case it brought seeking a declaration that it wasn't infringing a rival's patent covering animal-free egg protein, ruling Friday there was no imminent controversy between the companies when the lawsuit was filed.
-
October 13, 2026
The Federal Trade Commission and seven states asked a New York federal judge Tuesday to hold Martin Shkreli in contempt for violating a court order banning him from the pharmaceutical industry by trading in industry stocks and broadcasting opinions about the business since he was released from prison in 2022.
-
October 13, 2026
Corcept Therapeutics told a California federal court there's no evidence that it blocked generic competition for its cortisol disorder treatment Korlym, urging the court to toss an antitrust case from Teva Pharmaceuticals ahead of trial.
-
October 13, 2026
The Federal Circuit on Tuesday issued a one-word order affirming a California federal court's invalidation of a facial measurement and analysis patent that had been asserted against the cosmetic giant L'Oreal USA Inc.
-
October 13, 2026
A Delaware federal judge ruled Tuesday that a generic version of a cyanide antidote was infringing three patents asserted by Hope Medical Enterprises after a bench trial where Accord Healthcare Inc. claimed its product did not infringe and that the patents were invalid.
-
October 13, 2026
The Federal Circuit wrongly continued the degradation of the U.S. International Trade Commission's domestic industry requirement in patent disputes by sustaining a decision that Apple Watches infringe Masimo Corp.'s patents, groups supporting Apple's petition told the U.S. Supreme Court on Tuesday.
-
October 13, 2026
Steris PLC has agreed to acquire specialty surgical products business Xodus Medical Inc. and some affiliates for $2.1 billion, with Jones Day advising Steris and Morgan Lewis & Bockius LLP representing Xodus.
-
October 13, 2026
A pair of attorneys specializing in healthcare and life sciences litigation recently moved their practices to Troutman Pepper Locke LLP's offices in Philadelphia and New York City.
-
October 13, 2026
A mother in Massachusetts is entitled to pursue a new theory of liability against drugmaker Amgen Inc. over the death of her 25-year-old son after he took the company's then-recently approved migraine medication Aimovig in 2018, the First Circuit has found.
-
October 13, 2026
Haynes Boone has opened its first San Diego office to deepen its life sciences, healthcare and technology capabilities and has selected a co-chair of its biotechnology practice to lead its fourth workplace in California.
-
October 13, 2026
Dentons has hired a former K&L Gates LLP counsel as a partner in its Washington, D.C., office, where he will advise pharmaceutical, biotechnology and medical device companies on a range of matters related to regulatory and transactional oversight, the firm announced.
-
October 13, 2026
The Delaware Chancery Court last week saw stockholders challenge Nvidia Corp.'s roughly $20 billion deal with artificial intelligence chipmaker Groq Inc., Hertz Global Holdings Inc.'s electric vehicle strategy and more than $1.5 billion in Humana Inc. stock buybacks.
-
October 09, 2026
Two clinical-stage biotechnology firms, TRex Bio and Retension Pharmaceuticals, hit the public markets on Friday after raising a combined $162 million in their initial public offerings.
-
October 09, 2026
Sarepta Therapeutics Inc. no longer has to face a lawsuit accusing it of infringing a University of Pennsylvania gene therapy patent licensed by clinical-stage biotechnology company Regenxbio Inc. after the parties told a Delaware federal judge they agreed to end the case.
-
October 09, 2026
As the U.S. and other countries struggle to agree on new international protections for Indigenous knowledge, trade secret law is drawing renewed attention as a possible solution for material that communities actually keep confidential.
-
October 09, 2026
A Georgia woman sued Emory University and Emory Healthcare Inc. in state court, alleging they refused repeated requests to check on her son, who was later found unresponsive in a hospital parking deck and died of an accidental fentanyl overdose.
-
October 09, 2026
Kalshi Inc. opening prediction markets for clinical drug trials has raised a host of compliance concerns for attorneys, including the risk of insider trading among the wide swaths of stakeholders in the know about the trials, as well as the danger of compromising the trials themselves.
-
October 09, 2026
A Texas federal court has granted a joint motion to stay litigation by an Altria Group Inc. vape subsidiary challenging the U.S. Food and Drug Administration's premarket authorization rule, pausing proceedings while the FDA pursues rulemaking to replace the challenged framework.
-
October 09, 2026
The Tenth and Seventh circuits issued published opinions in two union retirement disputes, while the Sixth Circuit found that the Commonwealth of Kentucky's lawsuit against pharmacy benefit managers does not belong in state court, citing colorable federal preemption arguments. Here's more on those decisions and three other notable rulings involving the Employee Retirement Income Security Act that came down in September.
-
October 09, 2026
U.S. Patent and Trademark Office Director John Squires has instituted four new America Invents Act reviews at the Patent Trial and Appeal Board and turned down three in his newest mass order.
-
October 09, 2026
Eli Lilly and Co. has sued an Arizona weight loss clinic and three online sellers, alleging they are illegally selling products containing the pharmaceutical giant's investigational molecule that has not yet been approved for use in any drug, endangering consumers in a mockery of safety guidelines.
-
October 09, 2026
A New Jersey federal judge has thrown out a proposed class action alleging a genetic testing company misled consumers about the accuracy of in-vitro fertilization patient tests, ruling the plaintiffs failed to show they actually received inaccurate results.